Nitric oxide/nucleophile complexes: A unique class of nitric oxide-based vasodilators

Journal of Cardiovascular Pharmacology

Volumn 22, Issue , 1993, Pages S3-S9

  Morley, Deborah ^a   Keefer, Larry K ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Nitric oxide; Nucleophiles; Vascular smooth muscle; Vasodilation

Indexed keywords

ALBUMIN; AMINE; CARDIOVASCULAR AGENT; CYCLIC GMP; DIETHYLAMINE; ENZYME INHIBITOR; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; METHYLENE BLUE; N ACETYL S NITROSOPENICILLAMINE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; SPERMINE; SULFITE; SYDNONIMINE; THIOL; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANGINA PECTORIS; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG MECHANISM; DRUG MIXTURE; DRUG POTENCY; DRUG STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RABBIT; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMAL; CARDIOVASCULAR DISEASES; HUMAN; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; VASODILATION; VASODILATOR AGENTS;

EID: 0027379589     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-199300221-00003     Document Type: Article

References (29)

1. Ignarro LJ. Nitric oxide: a novei signal transduction mechanism for transcellular communication. Hypertension 1990;16:477-83.
2. Moneada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
3. Nakaki T, Nakayama M, Kato R. Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol 1990;189:347-53.
4. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007-18.
5. Lüscher TF, Vanhoutte PM. The endothelium: modulator of cardiovascular function. Boca Raton, FL: CRC Press, 1990.
6. Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz ML, Pitt B. Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 1989;79:287-91.
7. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-51.
8. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
9. Kaiser L. Heart failure, cardiovascular disease, and endothelium dependent relaxation. Heart Failure 1989;5:13-25.
10. Drago RS. Reactions of nitrogen(II) oxide. In: Colburn CB, ed. Free radicals in inorganic chemistry. Washington, DC: American Chemical Society, 1962:143-9. (Advances in chemistry series; no. 36).
11. Maragos CM, Morley D, Wink DA, et al. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide: vasorelaxant effects. J Med Chem 1991;34:3242-7.
12. Morley D, Maragos CM, Zhang X-Y, Boignon M, Wink DA, Keefer LK. Mechanism of vascular relaxation induced by the nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilators. J Cardiovasc Pharmacol 1993;21:670-6.
13. Ahlner J, Andersson RGG, Torfgård K, Axelsson KL. Organic nitrate esters: clinical use and mechanism of actions. Pharmacol Rev 1991;43:351-423.
14. Ignarro LJ, Lippton H, Edwards JC, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitro-prusside and nitric oxide: evidence for the involvement of -nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981;218:739-49.
15. Kowaluk EA, Fung H-L. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J Pharmacol Exp Ther 1990;255:1256-64.
16. Ignarro LJ, Gruetter CA. Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols. Biochim Biophys Acta 1980;631:221-31.
17. Abrams J. Tolerance to organic nitrates. Circulation 1986;74:1181-5.
18. Kuhn M, Förstermann U. Endothelium-dependent vasodilatation in human epicardial coronary arteries: effect of prolonged exposure to glyceryl trinitrate or SIN-1. J Cardiovasc Pharmacol 1989;14(suppl II):S47-54.
19. Bates JN, Baker MT, Guerra R Jr, Harrison DG. Nitric oxide generation from nitroprusside by vascular tissue: evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol 1991;42:S157-65.
20. Michenfelder JD, Tinker JH. Cyanide toxicity and thiosulfate protection during chronic administration of sodium nitroprusside in the dog: correlation with a human case. Anesthesiology 1977;47:441-8.
21. Wilcox DE, Kruszyna H, Kruszyna R, Smith RP. Effect of cyanide on the reaction of nitroprusside with hemoglobin: relevance to cyanide interference with the biological activity of nitroprusside. Chem Res Toxicol 1990;3:71-6.
22. Rudolph W, Dirschinger J. Effectiveness of molsidomine in the long-term treatment of exertional angina pectoris and chronic congestive heart failure. Am Heart J 1985;109:670-4.
23. Noack E, Feelisch M. Molecular aspects underlying the vasodilator action of molsidomine. J Cardiovasc Pharmacol 1989;14(suppl 11):S1-5.
24. Bohn H, Schönafinger K. Oxygen and oxidation promote the release of nitric oxide from sydnonimines. J Cardiovasc Pharmacol 1989;14(suppl 11):S6-12.
25. Diodati JG, Quyyumi AA, Keefer LK. Complexes of nitric oxide with nucleophiles as agents for the controlled biological release of nitric oxide: hemodynamic effect in the rabbit. J Cardiovasc Pharmacol 1993 (in press).
26. Diodati JG, Quyyumi AA, Hussain N, Keefer LK. Complexes of nitric oxide with nucleophiles as agents for the controlled biological release of nitric oxide: antiplatelet effect. Thromb Haemost 1993 (in press).
27. Vanderford PA, Wong J, Chang R, Keefer LK, Soifer SJ, Fineman JR. The diethylamine/nitric oxide adduct, a nitric oxide donor, produces potent pulmonary and systemic vasodilation in the intact newborn lamb. J Cardiovasc Pharmacol (in press).
28. 2N[N(o)NO]. O-Functionalization chemistry. J Org Chem 1992;57:6134-8.
29. Wink DA, Kasprzak KS, Maragos CM, et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991;254:1001-3.